Gene · 38
Papers2,780
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 2,780
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Short-term exposure to acrylamide exacerbated metabolic disorders and increased metabolic toxicity susceptibility on adult male mice with diabetes. | Toxicol Lett | 2022 | 34896238 | PubTator, text mining | PubMed |
Facile method to incorporate high-affinity ACAT/SOAT1 inhibitor F12511 into stealth liposome-based nanoparticle and demonstration of its efficacy in blocking cholesteryl ester biosynthesis without overt toxicity in neuronal cell culture. | J Neurosci Methods | 2022 | 34890698 | PubTator, text mining | PubMed |
| Wnt5a Promotes Lysosomal Cholesterol Egress and Protects Against Atherosclerosis. | Circ Res | 2022 | 34886684 | PubTator, text mining | PubMed |
| Mechanistic roles of mutant p53 governing lipid metabolism. | Adv Biol Regul | 2022 | 34840111 | PubTator, text mining | PubMed |
| Novel Branched-Chain Amino Acid-Catabolism Related Gene Signature for Overall Survival Prediction of Pancreatic Carcinoma. | J Proteome Res | 2022 | 34816714 | PubTator, text mining | PubMed |
| Intrauterine growth restriction elevates circulating acylcarnitines and suppresses fatty acid metabolism genes in the fetal sheep heart. | J Physiol | 2022 | 34802149 | PubTator, text mining | PubMed |
| Citrate Promotes Excessive Lipid Biosynthesis and Senescence in Tumor Cells for Tumor Therapy. | Adv Sci (Weinh) | 2022 | 34747157 | PubTator, text mining | PubMed |
| Lipid metabolism reprogramming in renal cell carcinoma. | Cancer Metastasis Rev | 2022 | 34741716 | PubTator, text mining | PubMed |
| Fine-Tuning of Cholesterol Homeostasis Controls Erythroid Differentiation. | Adv Sci (Weinh) | 2022 | 34739188 | PubTator, text mining | PubMed |
| ConVarT: a search engine for matching human genetic variants with variants from non-human species. | Nucleic Acids Res | 2022 | 34718716 | PubTator, text mining | PubMed |
| Gene Therapy Approach with an Emphasis on Growth Factors: Theoretical and Clinical Outcomes in Neurodegenerative Diseases. | Mol Neurobiol | 2022 | 34655056 | PubTator, text mining | PubMed |
| Crinecerfont Lowers Elevated Hormone Markers in Adults With 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia. | J Clin Endocrinol Metab | 2022 | 34653252 | PubTator, text mining | PubMed |
| β-Hydroxybutyrate Exacerbates Hypoxic Injury by Inhibiting HIF-1α-Dependent Glycolysis in Cardiomyocytes-Adding Fuel to the Fire? | Cardiovasc Drugs Ther | 2022 | 34652582 | PubTator, text mining | PubMed |
| Lessons in self-defence: inhibition of virus entry by intrinsic immunity. | Nat Rev Immunol | 2022 | 34646033 | PubTator, text mining | PubMed |
| Targeting cholesterol homeostasis in hematopoietic malignancies. | Blood | 2022 | 34610110 | PubTator, text mining | PubMed |
| The Mechanism and Consequences of SARS-CoV-2 Spike-Mediated Fusion and Syncytia Formation. | J Mol Biol | 2022 | 34606831 | PubTator, text mining | PubMed |
| Rare sugars: metabolic impacts and mechanisms of action: a scoping review. | Br J Nutr | 2022 | 34505561 | PubTator, text mining | PubMed |
| Metabolic checkpoints and novel approaches for immunotherapy against cancer. | Int J Cancer | 2022 | 34460110 | PubTator, text mining | PubMed |
| Potent Anticancer Activities of Beauvericin Against KB Cells In Vitro by Inhibiting the Expression of ACAT1 and Exploring Binding Affinity. | Anticancer Agents Med Chem | 2022 | 34353273 | PubTator, text mining | PubMed |
| Identification of Differentially-Methylated Genes and Pathways in Patients with Delayed Cerebral Ischemia Following Subarachnoid Hemorrhage. | J Korean Neurosurg Soc | 2022 | 34320780 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/38/papers?page=41